JP2016531924A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531924A5 JP2016531924A5 JP2016540383A JP2016540383A JP2016531924A5 JP 2016531924 A5 JP2016531924 A5 JP 2016531924A5 JP 2016540383 A JP2016540383 A JP 2016540383A JP 2016540383 A JP2016540383 A JP 2016540383A JP 2016531924 A5 JP2016531924 A5 JP 2016531924A5
- Authority
- JP
- Japan
- Prior art keywords
- binding
- heavy chain
- binding molecule
- igm
- chain constant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874277P | 2013-09-05 | 2013-09-05 | |
| US201361874284P | 2013-09-05 | 2013-09-05 | |
| US61/874,277 | 2013-09-05 | ||
| US61/874,284 | 2013-09-05 | ||
| PCT/US2014/054079 WO2015053887A1 (en) | 2013-09-05 | 2014-09-04 | Constant chain modified bispecific, penta- and hexavalent ig-m antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531924A JP2016531924A (ja) | 2016-10-13 |
| JP2016531924A5 true JP2016531924A5 (enExample) | 2017-10-12 |
| JP6721505B2 JP6721505B2 (ja) | 2020-07-15 |
Family
ID=51542496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540383A Expired - Fee Related JP6721505B2 (ja) | 2013-09-05 | 2014-09-04 | 定常領域が修飾された（ｃｏｎｓｔａｎｔ ｃｈａｉｎ ｍｏｄｉｆｉｅｄ）二重特異性五価及び六価Ｉｇ−Ｍ抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10351631B2 (enExample) |
| EP (1) | EP3041862B1 (enExample) |
| JP (1) | JP6721505B2 (enExample) |
| KR (1) | KR102306492B1 (enExample) |
| CN (1) | CN105722855B (enExample) |
| AU (1) | AU2014332458B2 (enExample) |
| CA (1) | CA2922830A1 (enExample) |
| DK (1) | DK3041862T3 (enExample) |
| WO (1) | WO2015053887A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| JP5764677B2 (ja) | 2011-02-28 | 2015-08-19 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 抗原結合タンパク質 |
| CA2824824A1 (en) | 2011-02-28 | 2012-09-07 | F. Hoffmann-La Roche Ag | Monovalent antigen binding proteins |
| BR112016006929A2 (pt) * | 2013-10-11 | 2017-09-19 | Hoffmann La Roche | Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo |
| AU2015213593B2 (en) | 2014-02-10 | 2020-09-03 | Igm Biosciences, Inc. | IgA multi-specific binding molecules |
| KR102380402B1 (ko) | 2014-04-03 | 2022-03-31 | 아이쥐엠 바이오사이언스 인코포레이티드 | 변형된 j-사슬 |
| EP3750918A1 (en) | 2015-01-20 | 2020-12-16 | IGM Biosciences, Inc. | Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof |
| CN115093479A (zh) * | 2015-03-04 | 2022-09-23 | Igm生物科学股份有限公司 | Cd20结合分子及其用途 |
| JP6882184B2 (ja) | 2015-03-25 | 2021-06-02 | アイジーエム バイオサイエンシズ インコーポレイテッド | 多価ｂ型肝炎ウイルス抗原結合分子およびその使用 |
| WO2016168758A1 (en) | 2015-04-17 | 2016-10-20 | Igm Biosciences, Inc. | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof |
| DK3355913T3 (da) | 2015-09-30 | 2024-12-02 | Igm Biosciences Inc | Bindingsmolekyler med modificeret j-kæde |
| US11639389B2 (en) | 2015-09-30 | 2023-05-02 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
| PL3455257T3 (pl) | 2016-05-09 | 2022-01-17 | Igm Biosciences Inc. | Przeciwciała anty-pd-l1 |
| US11401337B2 (en) | 2017-04-07 | 2022-08-02 | Igm Biosciences, Inc. | Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function |
| WO2019169314A1 (en) | 2018-03-01 | 2019-09-06 | Igm Biosciences, Inc. | IgM Fc AND J-CHAIN MUTATIONS THAT AFFECT IgM SERUM HALF-LIFE |
| CN114269785A (zh) | 2019-08-15 | 2022-04-01 | Igm生物科学股份有限公司 | 免疫刺激性多聚体结合分子 |
| US20230212293A1 (en) | 2020-04-22 | 2023-07-06 | Igm Biosciences, Inc. | Pd-1 agonist multimeric binding molecules |
| CA3245061A1 (en) | 2022-04-07 | 2023-10-12 | Repertoire Immune Medicines, Inc. | T-CELL RECEIVER MULTIMERS AND THEIR USES |
| WO2024073482A1 (en) * | 2022-09-28 | 2024-04-04 | Dren Bio, Inc. | Multispecific antibodies and methods of use thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8719963D0 (en) | 1987-08-24 | 1987-09-30 | Cattaneo A | Recombinant dna products |
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US20020062010A1 (en) * | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| DE602004027483D1 (de) | 2003-05-23 | 2010-07-15 | Crucell Holland Bv | Herstellung von rekombinanten igm in den per.c6 zellen |
| EP4353819A3 (en) * | 2004-07-22 | 2024-07-17 | Erasmus University Medical Center Rotterdam | Binding molecules |
| WO2006052641A2 (en) | 2004-11-05 | 2006-05-18 | Palingen, Inc. | Antibody induced cell membrane wounding |
| US8349332B2 (en) * | 2005-04-06 | 2013-01-08 | Ibc Pharmaceuticals, Inc. | Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases |
| SI2235064T1 (sl) * | 2008-01-07 | 2016-04-29 | Amgen Inc. | Metoda za izdelavo heterodimernih molekul - protitelesa fc z uporabo elektrostatičnih usmerjevalnih učinkov |
| US9676845B2 (en) * | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| US20130129723A1 (en) * | 2009-12-29 | 2013-05-23 | Emergent Product Development Seattle, Llc | Heterodimer Binding Proteins and Uses Thereof |
| CA2849765C (en) * | 2011-09-26 | 2021-10-19 | Jn Biosciences Llc | Hybrid constant regions |
| HRP20201004T1 (hr) * | 2011-12-20 | 2020-10-16 | Medimmune, Llc | Modificirani polipeptidi za skelete bispecifičnog protutijela |
| CA2863714C (en) | 2012-02-08 | 2022-07-05 | Igm Biosciences, Inc. | Cdim binding proteins and uses thereof |
| CA2936877C (en) | 2014-01-16 | 2023-03-28 | Mario Umberto Francesco MONDELLI | Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen |
| AU2015213593B2 (en) | 2014-02-10 | 2020-09-03 | Igm Biosciences, Inc. | IgA multi-specific binding molecules |
| KR102380402B1 (ko) | 2014-04-03 | 2022-03-31 | 아이쥐엠 바이오사이언스 인코포레이티드 | 변형된 j-사슬 |
| EP3750918A1 (en) | 2015-01-20 | 2020-12-16 | IGM Biosciences, Inc. | Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof |
| CN115093479A (zh) | 2015-03-04 | 2022-09-23 | Igm生物科学股份有限公司 | Cd20结合分子及其用途 |
| JP6882184B2 (ja) | 2015-03-25 | 2021-06-02 | アイジーエム バイオサイエンシズ インコーポレイテッド | 多価ｂ型肝炎ウイルス抗原結合分子およびその使用 |
| WO2016168758A1 (en) | 2015-04-17 | 2016-10-20 | Igm Biosciences, Inc. | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof |
| DK3355913T3 (da) | 2015-09-30 | 2024-12-02 | Igm Biosciences Inc | Bindingsmolekyler med modificeret j-kæde |
| US11639389B2 (en) | 2015-09-30 | 2023-05-02 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
| PL3455257T3 (pl) | 2016-05-09 | 2022-01-17 | Igm Biosciences Inc. | Przeciwciała anty-pd-l1 |
| US20190330374A1 (en) | 2016-07-20 | 2019-10-31 | Igm Biosciences, Inc. | Multimeric ox40 binding molecules and uses thereof |
| EP3496536A4 (en) | 2016-07-20 | 2020-02-12 | IGM Biosciences, Inc. | MULTIMERE CD40-BINDING MOLECULES AND USES THEREOF |
| US20190338040A1 (en) | 2016-07-20 | 2019-11-07 | Igm Biosciences, Inc. | Multimeric cd137/4-1bb binding molecules and uses thereof |
| US20190330360A1 (en) | 2016-07-20 | 2019-10-31 | Igm Biosciences, Inc. | Multimeric gitr binding molecules and uses thereof |
-
2014
- 2014-09-04 CA CA2922830A patent/CA2922830A1/en active Pending
- 2014-09-04 KR KR1020167007082A patent/KR102306492B1/ko not_active Expired - Fee Related
- 2014-09-04 DK DK14766628.3T patent/DK3041862T3/da active
- 2014-09-04 JP JP2016540383A patent/JP6721505B2/ja not_active Expired - Fee Related
- 2014-09-04 AU AU2014332458A patent/AU2014332458B2/en not_active Ceased
- 2014-09-04 US US14/916,166 patent/US10351631B2/en active Active
- 2014-09-04 CN CN201480051238.5A patent/CN105722855B/zh not_active Expired - Fee Related
- 2014-09-04 EP EP14766628.3A patent/EP3041862B1/en active Active
- 2014-09-04 WO PCT/US2014/054079 patent/WO2015053887A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531924A5 (enExample) | ||
| ES2885815T3 (es) | Nuevo formato biespecífico adecuado para su uso en el cribado de alto rendimiento | |
| JP2014518883A5 (enExample) | ||
| JP2019500862A5 (enExample) | ||
| JP2018537415A5 (enExample) | ||
| JP2017114866A5 (enExample) | ||
| JP2017529067A5 (enExample) | ||
| Maaß et al. | Cystine‐knot peptides targeting cancer‐relevant human cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) | |
| JP2019526273A5 (enExample) | ||
| US20180346603A1 (en) | Multispecific antibodies | |
| JP2020517287A5 (enExample) | ||
| HRP20251181T1 (hr) | Protutijela na protein gprc5d, bispecifične molekule koje vezuju antigen i koje vezuju gprc5d i cd3 te njihove primjene | |
| JP2017511130A5 (enExample) | ||
| JP2014158485A5 (enExample) | ||
| JP2016536322A5 (enExample) | ||
| HRP20201517T1 (hr) | Anti-cd3 protutijela, anti-cd123 protutijela i bispecifična protutijela koja se specifično vežu na cd3 i/ili cd123 | |
| JP2019522490A5 (enExample) | ||
| JP2016533174A5 (enExample) | ||
| JP2018516554A5 (enExample) | ||
| FI4050034T3 (fi) | Cd3:een sitoutuvia vasta-aineita | |
| JP2020500510A5 (enExample) | ||
| JP2019525738A5 (enExample) | ||
| JP2017504578A5 (enExample) | ||
| WO2009132020A3 (en) | Selective high-affinity polydentate ligands and methods of making such | |
| JP2017176174A5 (enExample) |